Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
暂无分享，去创建一个
S. Fosså | C. Parker | N. James | P. Hoskin | J. Logue | S. Nilsson | D. Bottomley | O. Sartor | O. Petrenciuc | N. Vogelzang | J. Kliment | J. O’Sullivan | R. Coleman | Ø. Bruland | I. Syndikus | S. Wedel | A. Widmark | D. Heinrich | S. Helle | A. Chodacki | P. Wiechno | M. Seke | D. Johannessen | A. Solberg | S. Boehmer | M. Dall'oglio | L. Franzén | K. Staudacher | Rui Li